Raise closed, search for fresh raises on Seedstage

Scottsdale, AZ

Advancing AI-powered, FDA-cleared diagnostics and therapies to prevent chronic disease before symptoms occur.

• FDA-cleared solution: ThermaLens™ offers non-invasive diagnostics already in clinical use.
• AI-powered insights: AiLLUMI™ provides fast, predictive analysis from a proprietary medical image database.
• Integrated care model: Combines early detection with physician-supervised nutritional therapy.
• Market alignment: Targets the fast-growing preventative health and AI diagnostics sectors.
• Scalable infrastructure: InfraREDMed™ ensures widespread physician adoption and proper clinical application.

Oxygen4Life is leveraging FDA-cleared infrared imaging and AI diagnostics to shift healthcare from a reactive model to a preventative one. Focused on chronic inflammation, a leading contributor to life-threatening diseases like diabetes, heart disease, and neuropathy, the company is developing and deploying an integrated suite of solutions that include early-detection imaging systems, proprietary AI software, physician training platforms, and patented medical foods. The company is addressing a multitrillion-dollar problem by enabling earlier, non-invasive identification of chronic illness—empowering both patients and providers with actionable insight before symptoms become critical.

The company’s ecosystem includes ThermaLens™, an FDA-cleared thermal imaging system; AiLLUMI™, an AI-powered diagnostic platform with a database of over one million medical images; Brivanta™, a physician-supervised medical food; and InfraREDMed™, a training and adoption platform for healthcare professionals. These offerings work together to detect and manage chronic disease early—supporting a market trend toward proactive, AI-driven, and non-invasive healthcare. Oxygen4Life is raising funds to support financial audits, conference attendance, personnel costs, and marketing efforts as it expands its reach in preventative medicine.

Company Info

Oxygen4Life uses AI-powered infrared imaging and patented medical solutions to enable early detection and treatment of chronic diseases.

Oxygen4Life is a preventative healthcare company focused on early detection and treatment of chronic inflammation and related diseases through a combination of FDA-cleared infrared imaging, AI diagnostics, and medical food solutions. The company addresses the limitations of traditional reactive healthcare by integrating non-invasive technologies and personalized care to improve patient outcomes. Its core technologies include ThermaLens™ IRIS-XP, an infrared imaging system; AiLLUMI™, an AI-powered diagnostics platform; Brivanta™, a patented medical food; and InfraREDMed™, a physician training program designed to drive adoption and clinical integration.

With a proprietary database of over 1 million medical images and patented solutions, Oxygen4Life aims to shift the healthcare model from symptom treatment to disease prevention and management. Its focus includes conditions such as neuropathy, cardiovascular disease, diabetes, PTSD, and chronic wounds. The company also supports medical professionals through tools that help detect, predict, and address inflammation-related illnesses early. Positioned at the intersection of biotechnology, medical imaging, and AI, Oxygen4Life is leveraging data-driven innovation to transform chronic disease care into a proactive, efficient, and scalable system.